Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2000
08/03/2000CA2360683A1 Antidepressant heterocyclic compounds
08/02/2000EP1024140A1 Process for N-alkylation of cyclic cyanoamidines
08/02/2000EP1024138A1 Pyrazole derivatives
08/02/2000EP1023265A1 Azetidinone derivatives for the treatment of hcmv infections
08/02/2000EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
08/02/2000EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000CN1261889A Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agent
08/02/2000CN1261881A 6-azauracil derivatives as IL-5 inhibitors
08/01/2000US6096904 Discodermolides
08/01/2000US6096898 One pot synthesis of 1,2,4-triazoles
08/01/2000US6096895 Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
08/01/2000US6096887 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
08/01/2000US6096840 Gas phase polymerization process
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096767 Muscarinic receptor agonists
08/01/2000US6096763 Administering to the patients a2-oxo-1-benzimidazolinyl)piperidin-1-yl)alkyl)-1,2benzisothia zol-3-(2h)-one derivative as alpha-1a adrenergic receptor antagonist
08/01/2000US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity
08/01/2000US6096751 Substituted 1,2,3,4-tetrahydro-55-nitro-pyrimidines
08/01/2000US6096736 Benzazepine derivatives with vasopressin agonistic activity
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096689 5-pyrazolylbenzoic acid derivatives as herbicides
07/2000
07/27/2000WO2000043535A2 Composition and device for detecting leukocytes in urine
07/27/2000WO2000043391A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
07/27/2000WO2000043388A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
07/27/2000WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043377A1 Herbicidal oxadiazolidines
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043013A1 Pharmaceutical compositions for alleviating discomfort
07/27/2000WO2000042868A1 Infant formula
07/27/2000WO2000027832A3 Thiazole derivatives as ppar gamma ligands
07/27/2000WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
07/27/2000WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
07/27/2000CA2627837A1 Pharmaceutical compositions for alleviating discomfort
07/27/2000CA2359689A1 Composition and device for detecting leukocytes in urine
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359108A1 Herbicidal oxadiazolidines
07/27/2000CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
07/27/2000CA2359103A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
07/27/2000CA2322990A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
07/26/2000EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use
07/26/2000EP1022272A1 Substituted fused heterocyclic compounds
07/26/2000EP1022270A1 Pyrazole derivatives
07/26/2000EP1022267A2 Process for the manufacture of diazonium compounds with a low sodium ions content
07/26/2000EP1021429A1 Aryl furan derivatives as pde iv inhibitors
07/26/2000EP1021424A1 Thiadiazole amide mmp inhibitors
07/26/2000EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION
07/26/2000EP1021411A1 Benzamide derivatives as thrombin inhibitors
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections
07/26/2000EP1021190A1 Novel amide derivatives
07/26/2000EP0694032B1 Method for preparing beta-lactams
07/26/2000CN1261370A Method of producing tiazofurin and other C-nucleosides
07/26/2000CN1261364A Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
07/26/2000CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives
07/26/2000CN1261356A Substituted aminobeterocyclylamides
07/26/2000CN1261276A Protease inhibitors
07/25/2000US6093821 Process for preparing steroid receptor modulator compounds
07/25/2000US6093737 2-oxo-piperidine substituted imidazole derivatives
07/25/2000US6093736 Antibacterial agents
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/25/2000US6093734 Pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs having a hydrolyzable sulfinyl or arylsulfonyl group attached to the benzimidazole nitrogen; gastrointestinal disorders
07/25/2000US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
07/25/2000US6093716 Substituted 2-pyrimidineamines and processes for their preparation
07/25/2000CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists
07/25/2000CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
07/20/2000WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042032A1 Substituted 2-imino thiazolines
07/20/2000WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000042023A1 Substituted imidazoles, their preparation and use
07/20/2000WO2000041697A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia
07/20/2000WO2000029406A3 Novel isoxazoline fibrinogen receptor antagonists
07/20/2000CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000CA2359390A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia
07/20/2000CA2296173A1 A process for the production of diazonium compounds with a low content of sodium ions
07/20/2000CA2296128A1 A process for the production of diazonium compounds with a low content of sodium ions
07/19/2000EP1020445A1 Fused pyridine derivatives
07/19/2000EP1019399A1 Aryl thiophene derivatives as pde iv inhibitors
07/19/2000EP1019389A2 Epothilone derivatives
07/19/2000EP1019387A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
07/19/2000EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors
07/19/2000EP1019385A1 Aminoaryl oxazolidinone n-oxides
07/19/2000EP1019378A1 Hypoglycemic and hypolipidemic compounds
07/19/2000EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019052A1 Alpha 1a adrenergic receptor antagonists
07/19/2000EP1019046A1 Protease inhibitors
07/19/2000EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
07/19/2000EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex